您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览62

Enzyme-inducing antiepileptic drugs AEDs have adverse effects on bone mineral density (BMD), whereas studies on levetiracetam (LEV), a nonenzyme-inducing agent, have showed conflicting results. The aim of this study was to further elucidate the role of LEV in bone health. A sample of forty-six patients with epilepsy (mean age: 35.7 years, range: 20.2-64.2 years, 39.1

作者:Artemios K, Artemiadis;Irene, Lambrinoudaki;Panagiota, Voskou;Georgios, Tsivgoulis;Apostolos, Safouris;Anastasia, Bougea;Sotiris, Giannopoulos;Stergios, Gatzonis;Nikolaos, Triantafyllou

来源:Epilepsy & behavior : E&B 2016 年 55卷

相似文献
知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:62
作者:
Artemios K, Artemiadis;Irene, Lambrinoudaki;Panagiota, Voskou;Georgios, Tsivgoulis;Apostolos, Safouris;Anastasia, Bougea;Sotiris, Giannopoulos;Stergios, Gatzonis;Nikolaos, Triantafyllou
来源:
Epilepsy & behavior : E&B 2016 年 55卷
标签:
Bone Density Levetiracetam Mineral Osteopenia Osteoporosis
Enzyme-inducing antiepileptic drugs AEDs have adverse effects on bone mineral density (BMD), whereas studies on levetiracetam (LEV), a nonenzyme-inducing agent, have showed conflicting results. The aim of this study was to further elucidate the role of LEV in bone health. A sample of forty-six patients with epilepsy (mean age: 35.7 years, range: 20.2-64.2 years, 39.1